NightHawk Biosciences Inc (NHWK)

[dia76ca]

Today(Sept.14,2016)there was a FDA Oncologic Drugs Advisory Committee Meeting to vote on the question "Has substantial evidence of a treatment effect for apaziquone over placebo been demonstrated?"

Apaziquone is Spectrum's(SPPI)drug for nonmuscle invasive bladder cancer indication. On the above question the committee voted NO-14, YES-0. This vote makes Heat's bladder cancer results all the more important!